| Financial Year |
March 31 2023 |
| Monetary Funds |
738,165,774.87 |
| Held-for-trading Financial Assets |
344,138,038.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,034,195,633.95 |
| Advances to Suppliers |
48,133,247.22 |
| Other Receivables |
36,282,930.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
531,032,343.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,000,000.00 |
| Other Current Assets |
29,530,698.27 |
| Total Current Assets |
2,848,466,585.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
204,880,220.51 |
| Long-term Equity Investment |
63,357,144.18 |
| Investment Properties |
23,547,625.68 |
| Fixed Assetes |
2,530,551,974.92 |
| Under-construction Projects |
567,069,885.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
381,472,376.05 |
| R&D expenses |
17,835,076.96 |
| Goodwill |
13,371,241.35 |
| Long-Term Deferred and Prepaid Expenses |
67,522,637.21 |
| Deferred Income Tax Assets |
37,914,567.89 |
| Other Non-Current Assets |
730,143.09 |
| Sub-Total of Non-Current Assets |
3,964,865,825.16 |
| Total Assets |
6,813,332,411.03 |
| Short-Term Loans |
629,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
133,500,000.00 |
| Accounts Payable |
97,851,516.32 |
| Accounts Received In Advance |
1,189,191.32 |
| Employee Compensation Payable |
10,330,762.19 |
| Taxes Payable |
44,074,552.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
138,760,002.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
154,514,280.53 |
| Other Current Liabilities |
3,011,405.02 |
| Sub-Total of Current Liabilities |
1,263,708,954.52 |
| Long-term Loans |
765,444,334.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
389,085,100.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,698,570.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,314,110,130.07 |
| Total Liabilities |
2,577,819,084.59 |
| Paid-In Capital(Or Share Stock) |
1,413,020,549.00 |
| Capital Surplus |
2,121,974,672.44 |
| Surplus Reserve |
67,757,169.75 |
| LESS:Treasury Stock |
25,411,869.00 |
| Undistributed Profits |
672,264,415.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,235,513,326.44 |
| Owner's Equity（Stockholder's Equity） |
4,235,513,326.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,813,332,411.03 |
